News & Statements
Patients vs. Pharma: Hagens Berman files complaint against 'Big Three' insulin producers
30 Jan 2017, 9:15 p.m. in #insulin4all USA, News & Statements by T1International
The law firm Hagens Berman has filed a complaint against Eli Lilly, Novo Nordisk, and Sanofi, the ‘big three’ pharmaceutical companies that hold a near-monopoly on the insulin market. People living with type 1 diabetes will be the plaintiffs in this class action lawsuit, which alleges that Eli Lilly, Novo Nordisk and Sanofi have unjustly inflated their prices. Read more
T1International Year in Review: 2016
10 Jan 2017, 12:13 p.m. in News & Statements by T1International
What did T1International achieve in 2016? Lots! We raised funds to get insulin to Syrians in need, we carried out our Insulin & Supply survey to show how unaffordable type 1 diabetes really is, we launched the Type 1 Access Charter as well as the Advocacy toolkit, and so much more! Read more
Eli Lilly and Novo Nordisk: More Empty Promises
19 Dec 2016, 9:01 a.m. in #insulin4all USA, News & Statements by Elizabeth Pfiester
Outrage at soaring insulin prices in the USA has been increasing. More patients and families are speaking out against unaffordable costs for life-saving medication than ever before. In response, two of the 'Big Three' insulin makers (who control over 90% of the insulin market) have recently made moves to combat this anger. Read more
Pharmadness: Your Chance to be a Pharma Company CEO
12 Dec 2016, 11:21 a.m. in #insulin4all USA, News & Statements by Elizabeth Pfiester
Last month the Missing Medicines campaign, of which T1International is proudly a member, launched a new interactive game to illustrate the problems with the global research and development model. This experience is something that everyone should a few minutes to try. Read more
T1International Statement on ADA Insulin Price Petition
18 Nov 2016, 8:24 a.m. in #insulin4all USA, News & Statements by T1International
It is fantastic to see a large diabetes organization speaking out in this way. However, we feel that the ADA’s language around the call for price transparency does not go far enough. Read more
Sign the Type 1 Diabetes Access Charter
5 Nov 2016, 4:53 p.m. in Global Stories, News & Statements by Elizabeth Pfiester
T1International is advocating for insulin and other vital diabetes supplies to be made available for everyone with diabetes through their Type 1 Diabetes Access Charter. Read more
T1International in Kenya: Part 3
1 Jun 2016, 9:09 p.m. in Global Stories, News & Statements by Elizabeth Pfiester
T1International recently had the opportunity to visit Kenya, and spent some time with our type 1 Global Advocate, Mbolonzi, who runs a non-profit called Diabetes Awareness Prevention and Management Kenya (DAPMK). We were lucky to join their meet up for people with diabetes. Read more
T1International in Kenya: Part 2
23 May 2016, 9:21 p.m. in Global Stories, News & Statements by Elizabeth Pfiester
T1International went to Kenya to support an NCD Child advocacy workshop there. While in Eldoret, we visited the diabetes clinic and then headed to Nairobi. This is part 2 of our series of blog posts from the visit. Read more
T1International in Kenya: Part 1
12 May 2016, 9:40 p.m. in Global Stories, News & Statements by Elizabeth Pfiester
T1International had the opportunity to visit Kenya and went on a clinic visit to Moi University Teaching Hospital in Eldoret. Read more
‘‘It would be cheaper for me to die’’
14 Apr 2016, 1:48 p.m. in #insulin4all USA, Global Stories, News & Statements by Elizabeth Pfiester
Since sharing our initial survey data about out-of-pocket costs for insulin and diabetes supplies, we have received even more responses. With an overwhelming number of USA respondents, our survey has collected comment after comment about the outrageous costs faced by Americans who must contend with this financial burden... Read more